Yaohai Bio-Pharma Launches Comprehensive Microbial Biologics CRDMO Platform
October 16, 2025
No Comments
Menu
Yaohai Bio-Pharma, founded in 2010, is a CRDMO specializing in microbial expression systems. We focus on the development and manufacturing of recombinant proteins, plasmids, nano-bodies, vaccines, mRNA, and circRNA, providing integrated CRO/CDMO/MAH services across the entire biologics lifecycle.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Advancing to become a global leader in microbial CRDMO
Obtained ISO certifications and EU QP qualification
Began developing an integrated global CRDMO platform
Expanded fermentation lines to 7,500 L total capacity
Added a pre-filled syringe DP line with an annual output of 10 million units
Series B funding exceeded RMB 100 million
Launched new production line
Series A funding of RMB 51 million
Expanded fermentation scale to 2,000L
Signed first MAH service agreement
Initiated new production line
Scaled manufacturing capacity
Entered microbial CDMO sector and began strategic focus
Commissioned an 8,000 m² GMP manufacturing facility
Obtained drug manufacturing license
Company founded in August, 2010; established in China Medical City, Taizhou
We are committed to complying with global regulations and upholding the highest standards of business ethics. We also protect clients’ intellectual property and data security, foster an ethical corporate culture, and enhance employee well-being.
Shaping Global Standards to Accelerate Drug Development and Advance Global Health.
To become a globally leading and sustainable partner in microbial CRDMO, driving long-term value for the biopharmaceutical industry.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Founder
Co-Founder
CEO
We enforce strict confidentiality and data protection standards across all operations, ensuring every service safeguards our clients’ intellectual property — the core of our shared trust.
We provide one-stop CRDMO solutions for biologics, with a strong focus on recombinant proteins, plasmids, nano-bodies, and novel recombinant vaccines.
We provide comprehensive CRDMO services—from CMC process development to MAH-based commercial production—enabling the full journey from DNA to commercialization.
Access the latest updates on company news, events, and technical articles.
Ut fames nibh euismod fermentum justo velit ultricies nunc duis placerat taciti. Torquent quam nisi integer fermentum accumsan litora. Efficitur potenti hac imperdiet laoreet vel vivamus placerat platea augue taciti. Dictum ultricies efficitur metus aliquet consectetuer pulvinar vivamus eget.
Ut fames nibh euismod fermentum justo velit ultricies nunc duis placerat taciti. Torquent quam nisi integer fermentum accumsan litora. Efficitur potenti hac imperdiet laoreet vel vivamus placerat platea augue taciti. Dictum ultricies efficitur metus aliquet consectetuer pulvinar vivamus eget.
Ut fames nibh euismod fermentum justo velit ultricies nunc duis placerat taciti. Torquent quam nisi integer fermentum accumsan litora. Efficitur potenti hac imperdiet laoreet vel vivamus placerat platea augue taciti. Dictum ultricies efficitur metus aliquet consectetuer pulvinar vivamus eget.
Ut fames nibh euismod fermentum justo velit ultricies nunc duis placerat taciti. Torquent quam nisi integer fermentum accumsan litora. Efficitur potenti hac imperdiet laoreet vel vivamus placerat platea augue taciti. Dictum ultricies efficitur metus aliquet consectetuer pulvinar vivamus eget.
Ut fames nibh euismod fermentum justo velit ultricies nunc duis placerat taciti. Torquent quam nisi integer fermentum accumsan litora. Efficitur potenti hac imperdiet laoreet vel vivamus placerat platea augue taciti. Dictum ultricies efficitur metus aliquet consectetuer pulvinar vivamus eget.
We prioritize energy efficiency use throughout all aspects of our operations. By implementing practical measures, minimizing waste, promoting recycling, and reducing emissions, we actively work to lower our environmental footprint and protect the planet.
